Pinnacle Wealth Planning Services, Inc. Biocryst Pharmaceuticals Inc Transaction History
Pinnacle Wealth Planning Services, Inc.
- $733 Million
- Q3 2024
A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 24,744 shares of BCRX stock, worth $185,332. This represents 0.03% of its overall portfolio holdings.
Number of Shares
24,744
Previous 23,036
7.41%
Holding current value
$185,332
Previous $142,000
32.39%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding BCRX
# of Institutions
280Shares Held
172MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$152 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$149 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$88.9 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$68 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$66.3 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.39B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...